Aclaris Therapeutics Ownership 2024 | Who Owns Aclaris Therapeutics Now?
Institutional Ownership
72.71%
Insider Ownership
2.64%
Retail Ownership
24.65%
Institutional Holders
88.00
Aclaris Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 18.27% | 10.20% | 12,988,134 | 3,592,200 | 38.23% | 14,286,947 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.60% | 0.00% | 4,687,551 | -242,224 | -4.91% | 5,156,306 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.69% | 0.00% | 3,336,850 | 63,358 | 1.94% | 3,670,535 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 4.67% | 0.00% | 3,320,206 | 37,224 | 1.13% | 3,652,227 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.87% | 0.09% | 2,753,495 | - | - | 3,028,845 | Jun 30, 2024 |
| BLACKROCK INC. | 2.86% | 0.00% | 2,032,155 | -3,169,992 | -60.94% | 2,235,371 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.71% | 1.95% | 1,927,446 | 1,927,446 | 100.00% | 2,120,191 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.69% | 0.01% | 1,913,449 | -221,918 | -10.39% | 2,103,000 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 2.66% | 0.26% | 1,892,050 | 1,892,050 | 100.00% | 2,081,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.57% | 0.00% | 1,113,072 | -216,544 | -16.29% | 1,224,379 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.41% | 0.12% | 1,000,000 | -2,000,000 | -66.67% | 1,100,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.32% | 0.00% | 940,752 | -271,508 | -22.40% | 1,034,827 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.30% | 0.00% | 923,313 | -33,708 | -3.52% | 1,015,644 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.30% | 0.00% | 922,200 | -751,200 | -44.89% | 1,014,420 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.29% | 0.00% | 916,620 | 770,808 | 528.63% | 1,008,282 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.21% | 0.88% | 858,152 | 858,152 | 100.00% | 943,967 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.09% | 0.00% | 774,137 | -790,917 | -50.54% | 851,714 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.98% | 0.16% | 696,171 | - | - | 765,788 | Jun 30, 2024 |
| FMR LLC | 0.97% | - | 689,353 | 17,525 | 2.61% | 758,288 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 0.80% | 0.07% | 569,832 | - | - | 626,815 | Jun 30, 2024 |
Aclaris Therapeutics's largest institutional shareholder is BML CAPITAL MANAGEMENT, LLC, holding 18.27% of the company's total share outstanding, currently valued at $14.29M. The top 10 institutional shareholders own together 50.60% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 18.27% | 10.20% | 12,988,134 | 3,592,200 | 38.23% | 14,286,947 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.71% | 1.95% | 1,927,446 | 1,927,446 | 100.00% | 2,120,191 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.21% | 0.88% | 858,152 | 858,152 | 100.00% | 943,967 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.65% | 0.27% | 464,120 | 2,457 | 0.53% | 510,532 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 2.66% | 0.26% | 1,892,050 | 1,892,050 | 100.00% | 2,081,000 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 0.61% | 0.21% | 434,455 | - | - | 477,901 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.98% | 0.16% | 696,171 | - | - | 765,788 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.10% | 0.13% | 72,091 | -7,902 | -9.88% | 79,300 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.41% | 0.12% | 1,000,000 | -2,000,000 | -66.67% | 1,100,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.87% | 0.09% | 2,753,495 | - | - | 3,028,845 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 0.80% | 0.07% | 569,832 | - | - | 626,815 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.25% | 0.03% | 177,909 | 177,909 | 100.00% | 195,700 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.47% | 0.03% | 336,677 | -342,460 | -50.43% | 370,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.15% | 0.02% | 107,929 | 107,929 | 100.00% | 118,722 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.12% | 0.02% | 83,979 | - | - | 92,377 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.37% | 0.01% | 264,377 | - | - | 290,815 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.16% | 0.01% | 114,806 | 114,806 | 100.00% | 126,287 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.69% | 0.01% | 1,913,449 | -221,918 | -10.39% | 2,103,000 | Jun 30, 2024 |
| BBR PARTNERS, LLC | 0.08% | 0.01% | 60,000 | - | - | 66,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 150,700 | 150,700 | 100.00% | 165,770 | Jun 30, 2024 |
The largest Aclaris Therapeutics shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 12.99M shares of Aclaris Therapeutics (ACRS), representing 10.20% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 18.27% | 10.20% | 12,988,134 | 3,592,200 | 38.23% | 14,286,947 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.71% | 1.95% | 1,927,446 | 1,927,446 | 100.00% | 2,120,191 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 2.66% | 0.26% | 1,892,050 | 1,892,050 | 100.00% | 2,081,000 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.21% | 0.88% | 858,152 | 858,152 | 100.00% | 943,967 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.29% | 0.00% | 916,620 | 770,808 | 528.63% | 1,008,282 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.25% | 0.03% | 177,909 | 177,909 | 100.00% | 195,700 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 150,700 | 150,700 | 100.00% | 165,770 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 117,966 | 117,966 | 100.00% | 129,763 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.16% | 0.01% | 114,806 | 114,806 | 100.00% | 126,287 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.15% | 0.02% | 107,929 | 107,929 | 100.00% | 118,722 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 94,687 | 94,687 | 100.00% | 104,156 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.00% | 81,005 | 81,005 | 100.00% | 89,000 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.11% | 0.00% | 79,200 | 79,200 | 100.00% | 87,120 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 4.69% | 0.00% | 3,336,850 | 63,358 | 1.94% | 3,670,535 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 4.67% | 0.00% | 3,320,206 | 37,224 | 1.13% | 3,652,227 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 35,794 | 35,794 | 100.00% | 39,373 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 35,300 | 35,300 | 100.00% | 38,830 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.20% | - | 139,400 | 29,633 | 27.00% | 154,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.12% | 0.00% | 82,883 | 29,048 | 53.96% | 91,171 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 22,524 | 22,524 | 100.00% | 24,776 | Jun 30, 2024 |
As of Jun 30 2024, Aclaris Therapeutics's largest institutional buyer is BML CAPITAL MANAGEMENT, LLC. The company purchased 3.59M stocks of ACRS, valued at $14.29M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.86% | 0.00% | 2,032,155 | -3,169,992 | -60.94% | 2,235,371 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.41% | 0.12% | 1,000,000 | -2,000,000 | -66.67% | 1,100,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 196,621 | -1,141,818 | -85.31% | 216,283,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.09% | 0.00% | 774,137 | -790,917 | -50.54% | 851,714 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.30% | 0.00% | 922,200 | -751,200 | -44.89% | 1,014,420 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.47% | 0.03% | 336,677 | -342,460 | -50.43% | 370,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.26% | - | 186,343 | -305,323 | -62.10% | 204,977 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.32% | 0.00% | 940,752 | -271,508 | -22.40% | 1,034,827 | Jun 30, 2024 |
| STRS OHIO | - | - | - | -264,700 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.60% | 0.00% | 4,687,551 | -242,224 | -4.91% | 5,156,306 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 3,399 | -237,702 | -98.59% | 3,739 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -232,771 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.54% | 0.00% | 386,177 | -226,028 | -36.92% | 424,795 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.69% | 0.01% | 1,913,449 | -221,918 | -10.39% | 2,103,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.57% | 0.00% | 1,113,072 | -216,544 | -16.29% | 1,224,379 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -166,656 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.37% | 0.00% | 260,706 | -158,628 | -37.83% | 286,777 | Jun 30, 2024 |
| MAN GROUP PLC | 0.17% | 0.00% | 118,459 | -129,216 | -52.17% | 130,305 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.01% | - | 5,549 | -128,282 | -95.85% | 6,104,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 24,452 | -98,648 | -80.14% | 26,897 | Jun 30, 2024 |
As of Jun 30 2024, Aclaris Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -3.17M shares of ACRS, valued at $2.24M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.71% | 1.95% | 1,927,446 | 1,927,446 | 100.00% | 2,120,191 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 2.66% | 0.26% | 1,892,050 | 1,892,050 | 100.00% | 2,081,000 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.21% | 0.88% | 858,152 | 858,152 | 100.00% | 943,967 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.25% | 0.03% | 177,909 | 177,909 | 100.00% | 195,700 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 150,700 | 150,700 | 100.00% | 165,770 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 117,966 | 117,966 | 100.00% | 129,763 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.16% | 0.01% | 114,806 | 114,806 | 100.00% | 126,287 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.15% | 0.02% | 107,929 | 107,929 | 100.00% | 118,722 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.00% | 81,005 | 81,005 | 100.00% | 89,000 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.11% | 0.00% | 79,200 | 79,200 | 100.00% | 87,120 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 35,794 | 35,794 | 100.00% | 39,373 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 35,300 | 35,300 | 100.00% | 38,830 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 22,524 | 22,524 | 100.00% | 24,776 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 18,319 | 18,319 | 100.00% | 20,151 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 13,910 | 13,910 | 100.00% | 15,301 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.02% | 0.00% | 11,622 | 11,622 | 100.00% | 13,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.01% | 0.00% | 10,466 | 10,466 | 100.00% | 9,376 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 3,497 | 3,497 | 100.00% | 3,847 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,632 | 1,632 | 100.00% | 1,796 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 527 | 527 | 100.00% | 580 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | - | 56 | 56 | 100.00% | 62 | Jun 30, 2024 |
Aclaris Therapeutics's largest new institutional shareholder by number of shares is STONEPINE CAPITAL MANAGEMENT, LLC, purchased 1.93M shares, valued at $2.12M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STRS OHIO | - | - | - | -264,700 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -232,771 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -166,656 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -62,974 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -60,400 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -46,358 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -34,229 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -32,843 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -30,984 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -30,498 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -18,694 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -17,654 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,114 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -14,788 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -13,033 | -100.00% | - | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -9,646 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -6,982 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -6,900 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -2,307 | -100.00% | - | Jun 30, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | - | - | -580 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -124 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
Aclaris Therapeutics's largest sold out institutional shareholder by shares sold is STRS OHIO, sold -0.26M shares, valued at -, as of undefined.
Aclaris Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 1.10% | 271,395 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.23% | 5,203 | 4,496 | 635.93% | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 44,964 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.06% | 185,411 | 132,115 | 247.89% | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 132,900 | - | - | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.04% | 89,846 | - | - | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 6,060 | - | - | Mar 28, 2024 |
| VANGUARD HORIZON FUNDS | 0.03% | 706,504 | -706,504 | -50.00% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.03% | 60,889 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.02% | 75,030 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.02% | 70,276 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 123,478 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 218,000 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,759 | - | - | Mar 31, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 1,365 | - | - | Dec 29, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 577,162 | 129,251 | 28.86% | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 60,443 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 627,784 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,604 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 435,589 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,820,160 | -734,532 | -20.66% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 134,507 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 73,649 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.01% | 12,953 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 43,885 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 186,021 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 50,005 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 140,818 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,900 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 241,684 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 47,442 | 1,252 | 2.71% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 26,398 | -1,102 | -4.01% | Mar 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 392,278 | -155,308 | -28.36% | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 217,727 | - | - | Mar 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 359,258 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 6,110 | - | - | Mar 28, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 26,849 | -435 | -1.59% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 40,404 | - | - | Mar 31, 2024 |
| Ultimus Managers Trust | 0.00% | 14,818 | - | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 4,994 | - | - | Mar 28, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 108,150 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,438 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 6,735 | - | - | Aug 31, 2023 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 161,450 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 176,350 | -222 | -0.13% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 7,300 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 4,200 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 28,525 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,922 | -1,375 | -13.35% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,483 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 170,913 | 1,244 | 0.73% | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,104 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 51,862 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 29,904 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2,383 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 256 | - | - | Apr 30, 2021 |
| SCHWAB STRATEGIC TRUST | 0.00% | 258,412 | -22,511 | -8.01% | Feb 29, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 9,954 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 9,539 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 300 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 997 | -1,440 | -59.09% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 158,672 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 22,437 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,831 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 15,791 | - | - | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 4,400 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 77,122 | - | - | Jan 31, 2024 |
| Series Portfolios Trust | 0.00% | 1,546 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,853 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 26,937 | -7,253 | -21.21% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 3,074,177 | -347,171 | -10.15% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,223 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 316,329 | 37,439 | 13.42% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 186,273 | 88 | 0.05% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 159,843 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 155,201 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 633 | - | - | Dec 31, 2023 |
| LoCorr Investment Trust | 0.00% | 3,773 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 2,837 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 16,300 | 800 | 5.16% | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 118,666 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 26,654 | -107 | -0.40% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 262,958 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 10,643 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,417 | -595 | -5.40% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 314 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 2,100 | - | - | Mar 28, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 30,760 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 15,469 | 1,981 | 14.69% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,867 | - | - | Feb 29, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 487,136 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,143 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 5,008 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 299 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 10,908 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 540 | -44 | -7.53% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 6,514 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,869 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,568 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 41 | - | - | Dec 31, 2023 |
Aclaris Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 271.39K shares, compromising 1.10% of its total assets.
Aclaris Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 88 | -10.20% |
| 31 Mar, 24 | 98 | -9.26% |
| 31 Dec, 23 | 108 | -32.92% |
| 30 Sep, 23 | 161 | 7.33% |
| 30 Jun, 23 | 150 | -13.29% |
| 31 Mar, 23 | 173 | 32.06% |
| 31 Dec, 22 | 131 | 3.97% |
| 30 Sep, 22 | 126 | 10.53% |
| 30 Jun, 22 | 114 | - |
| 31 Mar, 22 | 114 | -16.79% |
| 31 Dec, 21 | 137 | 3.79% |
| 30 Sep, 21 | 132 | -3.65% |
| 30 Jun, 21 | 137 | 30.48% |
| 31 Mar, 21 | 105 | 22.09% |
| 31 Dec, 20 | 86 | 56.36% |
| 30 Sep, 20 | 55 | -5.17% |
| 30 Jun, 20 | 58 | -13.43% |
| 31 Mar, 20 | 67 | -11.84% |
| 31 Dec, 19 | 76 | -3.80% |
| 30 Sep, 19 | 79 | -8.14% |
| 30 Jun, 19 | 86 | -10.42% |
| 31 Mar, 19 | 96 | -1.03% |
| 31 Dec, 18 | 97 | 15.48% |
| 30 Sep, 18 | 84 | -13.40% |
| 30 Jun, 18 | 97 | -4.90% |
| 31 Mar, 18 | 102 | -1.92% |
| 31 Dec, 17 | 104 | -2.80% |
| 30 Sep, 17 | 107 | 2.88% |
| 30 Jun, 17 | 104 | -9.57% |
| 31 Mar, 17 | 115 | 15.00% |
| 31 Dec, 16 | 100 | 69.49% |
| 30 Sep, 16 | 59 | 22.92% |
| 30 Jun, 16 | 48 | 41.18% |
| 31 Mar, 16 | 34 | 3.03% |
| 31 Dec, 15 | 33 | - |
As of 30 Jun 24, 88 institutions are holding Aclaris Therapeutics's shares, representing a decrease of -10.20% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 51,679,241 | -5.06% |
| 31 Mar, 24 | 54,434,983 | -6.90% |
| 31 Dec, 23 | 58,470,532 | -16.56% |
| 30 Sep, 23 | 70,071,814 | -1.45% |
| 30 Jun, 23 | 71,102,857 | -0.71% |
| 31 Mar, 23 | 71,610,647 | 8.62% |
| 31 Dec, 22 | 65,928,675 | 3.71% |
| 30 Sep, 22 | 63,568,874 | 0.47% |
| 30 Jun, 22 | 63,269,842 | 6.53% |
| 31 Mar, 22 | 59,392,047 | 5.97% |
| 31 Dec, 21 | 56,046,088 | -1.30% |
| 30 Sep, 21 | 56,786,245 | 1.39% |
| 30 Jun, 21 | 56,005,020 | 23.34% |
| 31 Mar, 21 | 45,405,948 | 42.18% |
| 31 Dec, 20 | 31,934,556 | 24.97% |
| 30 Sep, 20 | 25,554,120 | -10.21% |
| 30 Jun, 20 | 28,460,085 | -11.30% |
| 31 Mar, 20 | 32,087,370 | 4.11% |
| 31 Dec, 19 | 30,821,770 | 5.99% |
| 30 Sep, 19 | 29,079,557 | -18.37% |
| 30 Jun, 19 | 35,622,360 | -5.96% |
| 31 Mar, 19 | 37,880,951 | -3.02% |
| 31 Dec, 18 | 39,060,284 | 31.69% |
| 30 Sep, 18 | 29,659,952 | -4.32% |
| 30 Jun, 18 | 30,999,407 | 0.95% |
| 31 Mar, 18 | 30,706,323 | 7.67% |
| 31 Dec, 17 | 28,517,884 | 0.05% |
| 30 Sep, 17 | 28,502,746 | 11.30% |
| 30 Jun, 17 | 25,609,947 | 4.89% |
| 31 Mar, 17 | 24,415,072 | 14.35% |
| 31 Dec, 16 | 21,351,910 | 37.66% |
| 30 Sep, 16 | 15,510,243 | 0.75% |
| 30 Jun, 16 | 15,395,154 | 5.41% |
| 31 Mar, 16 | 14,605,450 | 41.96% |
| 31 Dec, 15 | 10,288,591 | - |
Aclaris Therapeutics (ACRS) has 51.68M shares outstanding as of 30 Jun 24, down -5.06% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 72.71% | 1.23% |
| 31 Mar, 24 | 76.81% | 1.13% |
| 31 Dec, 23 | 82.58% | 0.84% |
| 30 Sep, 23 | 99.20% | 0.88% |
| 30 Jun, 23 | 106.33% | 0.93% |
| 31 Mar, 23 | 107.08% | 1.10% |
| 31 Dec, 22 | 98.86% | 1.09% |
| 30 Sep, 22 | 95.34% | 1.04% |
| 30 Jun, 22 | 95.88% | 1.03% |
| 31 Mar, 22 | 96.68% | 1.15% |
| 31 Dec, 21 | 91.54% | 1.06% |
| 30 Sep, 21 | 92.76% | 0.86% |
| 30 Jun, 21 | 103.77% | 1.28% |
| 31 Mar, 21 | 90.20% | 1.68% |
| 31 Dec, 20 | 73.26% | 2.06% |
| 30 Sep, 20 | 59.70% | 1.31% |
| 30 Jun, 20 | 67.55% | 1.14% |
| 31 Mar, 20 | 77.10% | 1.39% |
| 31 Dec, 19 | 74.59% | 1.51% |
| 30 Sep, 19 | 70.30% | 0.94% |
| 30 Jun, 19 | 86.31% | 1.02% |
| 31 Mar, 19 | 91.84% | 0.90% |
| 31 Dec, 18 | 100.77% | 1.10% |
| 30 Sep, 18 | 95.73% | 0.95% |
| 30 Jun, 18 | 100.18% | 1.01% |
| 31 Mar, 18 | 99.42% | 1.16% |
| 31 Dec, 17 | 92.47% | 0.95% |
| 30 Sep, 17 | 98.85% | 1.07% |
| 30 Jun, 17 | 96.30% | 1.10% |
| 31 Mar, 17 | 93.61% | 1.12% |
| 31 Dec, 16 | 91.28% | 1.74% |
| 30 Sep, 16 | 72.42% | 1.30% |
| 30 Jun, 16 | 74.51% | 1.42% |
| 31 Mar, 16 | 72.41% | 2.18% |
| 31 Dec, 15 | 57.70% | - |
As of 30 Jun 24, Aclaris Therapeutics is held by 72.71% institutional shareholders, representing a 1.23% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 39 | -9.30% |
| 31 Mar, 24 | 43 | -29.51% |
| 31 Dec, 23 | 61 | -28.24% |
| 30 Sep, 23 | 85 | 25.00% |
| 30 Jun, 23 | 68 | -20.00% |
| 31 Mar, 23 | 85 | 41.67% |
| 31 Dec, 22 | 60 | -10.45% |
| 30 Sep, 22 | 67 | 8.06% |
| 30 Jun, 22 | 62 | 29.17% |
| 31 Mar, 22 | 48 | -38.46% |
| 31 Dec, 21 | 78 | 11.43% |
| 30 Sep, 21 | 70 | -22.22% |
| 30 Jun, 21 | 90 | 36.36% |
| 31 Mar, 21 | 66 | 43.48% |
| 31 Dec, 20 | 46 | 155.56% |
| 30 Sep, 20 | 18 | -25.00% |
| 30 Jun, 20 | 24 | -14.29% |
| 31 Mar, 20 | 28 | -17.65% |
| 31 Dec, 19 | 34 | - |
| 30 Sep, 19 | 34 | -27.66% |
| 30 Jun, 19 | 47 | -7.84% |
| 31 Mar, 19 | 51 | -21.54% |
| 31 Dec, 18 | 65 | 75.68% |
| 30 Sep, 18 | 37 | -28.85% |
| 30 Jun, 18 | 52 | -14.75% |
| 31 Mar, 18 | 61 | 3.39% |
| 31 Dec, 17 | 59 | -11.94% |
| 30 Sep, 17 | 67 | -6.94% |
| 30 Jun, 17 | 72 | - |
| 31 Mar, 17 | 72 | -19.10% |
| 31 Dec, 16 | 89 | 128.21% |
| 30 Sep, 16 | 39 | -2.50% |
| 30 Jun, 16 | 40 | 81.82% |
| 31 Mar, 16 | 22 | -33.33% |
| 31 Dec, 15 | 33 | - |
39 institutional shareholders have increased their position in ACRS stock as of 30 Jun 24 compared to 43 in the previous quarter (a -9.30% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 35 | -10.26% |
| 31 Mar, 24 | 39 | 44.44% |
| 31 Dec, 23 | 27 | -25.00% |
| 30 Sep, 23 | 36 | -7.69% |
| 30 Jun, 23 | 39 | -7.14% |
| 31 Mar, 23 | 42 | 13.51% |
| 31 Dec, 22 | 37 | 48.00% |
| 30 Sep, 22 | 25 | -7.41% |
| 30 Jun, 22 | 27 | -38.64% |
| 31 Mar, 22 | 44 | 18.92% |
| 31 Dec, 21 | 37 | -2.63% |
| 30 Sep, 21 | 38 | 26.67% |
| 30 Jun, 21 | 30 | 20.00% |
| 31 Mar, 21 | 25 | 8.70% |
| 31 Dec, 20 | 23 | 15.00% |
| 30 Sep, 20 | 20 | - |
| 30 Jun, 20 | 20 | -13.04% |
| 31 Mar, 20 | 23 | -8.00% |
| 31 Dec, 19 | 25 | -10.71% |
| 30 Sep, 19 | 28 | 3.70% |
| 30 Jun, 19 | 27 | 12.50% |
| 31 Mar, 19 | 24 | 20.00% |
| 31 Dec, 18 | 20 | -25.93% |
| 30 Sep, 18 | 27 | -3.57% |
| 30 Jun, 18 | 28 | - |
| 31 Mar, 18 | 28 | -17.65% |
| 31 Dec, 17 | 34 | 36.00% |
| 30 Sep, 17 | 25 | 13.64% |
| 30 Jun, 17 | 22 | -33.33% |
| 31 Mar, 17 | 33 | 371.43% |
| 31 Dec, 16 | 7 | -30.00% |
| 30 Sep, 16 | 10 | 100.00% |
| 30 Jun, 16 | 5 | -16.67% |
| 31 Mar, 16 | 6 | - |
| 31 Dec, 15 | - | - |
35 institutional shareholders have reduced their position in ACRS stock as of 30 Jun 24 compared to 39 in the previous quarter (a -10.26% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 88 | -10.20% | 51,679,241 | -5.06% | 72.71% | 1.23% | 39 | -9.30% | 35 | -10.26% |
| 31 Mar, 24 | 98 | -9.26% | 54,434,983 | -6.90% | 76.81% | 1.13% | 43 | -29.51% | 39 | 44.44% |
| 31 Dec, 23 | 108 | -32.92% | 58,470,532 | -16.56% | 82.58% | 0.84% | 61 | -28.24% | 27 | -25.00% |
| 30 Sep, 23 | 161 | 7.33% | 70,071,814 | -1.45% | 99.20% | 0.88% | 85 | 25.00% | 36 | -7.69% |
| 30 Jun, 23 | 150 | -13.29% | 71,102,857 | -0.71% | 106.33% | 0.93% | 68 | -20.00% | 39 | -7.14% |
| 31 Mar, 23 | 173 | 32.06% | 71,610,647 | 8.62% | 107.08% | 1.10% | 85 | 41.67% | 42 | 13.51% |
| 31 Dec, 22 | 131 | 3.97% | 65,928,675 | 3.71% | 98.86% | 1.09% | 60 | -10.45% | 37 | 48.00% |
| 30 Sep, 22 | 126 | 10.53% | 63,568,874 | 0.47% | 95.34% | 1.04% | 67 | 8.06% | 25 | -7.41% |
| 30 Jun, 22 | 114 | - | 63,269,842 | 6.53% | 95.88% | 1.03% | 62 | 29.17% | 27 | -38.64% |
| 31 Mar, 22 | 114 | -16.79% | 59,392,047 | 5.97% | 96.68% | 1.15% | 48 | -38.46% | 44 | 18.92% |
| 31 Dec, 21 | 137 | 3.79% | 56,046,088 | -1.30% | 91.54% | 1.06% | 78 | 11.43% | 37 | -2.63% |
| 30 Sep, 21 | 132 | -3.65% | 56,786,245 | 1.39% | 92.76% | 0.86% | 70 | -22.22% | 38 | 26.67% |
| 30 Jun, 21 | 137 | 30.48% | 56,005,020 | 23.34% | 103.77% | 1.28% | 90 | 36.36% | 30 | 20.00% |
| 31 Mar, 21 | 105 | 22.09% | 45,405,948 | 42.18% | 90.20% | 1.68% | 66 | 43.48% | 25 | 8.70% |
| 31 Dec, 20 | 86 | 56.36% | 31,934,556 | 24.97% | 73.26% | 2.06% | 46 | 155.56% | 23 | 15.00% |
| 30 Sep, 20 | 55 | -5.17% | 25,554,120 | -10.21% | 59.70% | 1.31% | 18 | -25.00% | 20 | - |
| 30 Jun, 20 | 58 | -13.43% | 28,460,085 | -11.30% | 67.55% | 1.14% | 24 | -14.29% | 20 | -13.04% |
| 31 Mar, 20 | 67 | -11.84% | 32,087,370 | 4.11% | 77.10% | 1.39% | 28 | -17.65% | 23 | -8.00% |
| 31 Dec, 19 | 76 | -3.80% | 30,821,770 | 5.99% | 74.59% | 1.51% | 34 | - | 25 | -10.71% |
| 30 Sep, 19 | 79 | -8.14% | 29,079,557 | -18.37% | 70.30% | 0.94% | 34 | -27.66% | 28 | 3.70% |
| 30 Jun, 19 | 86 | -10.42% | 35,622,360 | -5.96% | 86.31% | 1.02% | 47 | -7.84% | 27 | 12.50% |
| 31 Mar, 19 | 96 | -1.03% | 37,880,951 | -3.02% | 91.84% | 0.90% | 51 | -21.54% | 24 | 20.00% |
| 31 Dec, 18 | 97 | 15.48% | 39,060,284 | 31.69% | 100.77% | 1.10% | 65 | 75.68% | 20 | -25.93% |
| 30 Sep, 18 | 84 | -13.40% | 29,659,952 | -4.32% | 95.73% | 0.95% | 37 | -28.85% | 27 | -3.57% |
| 30 Jun, 18 | 97 | -4.90% | 30,999,407 | 0.95% | 100.18% | 1.01% | 52 | -14.75% | 28 | - |
| 31 Mar, 18 | 102 | -1.92% | 30,706,323 | 7.67% | 99.42% | 1.16% | 61 | 3.39% | 28 | -17.65% |
| 31 Dec, 17 | 104 | -2.80% | 28,517,884 | 0.05% | 92.47% | 0.95% | 59 | -11.94% | 34 | 36.00% |
| 30 Sep, 17 | 107 | 2.88% | 28,502,746 | 11.30% | 98.85% | 1.07% | 67 | -6.94% | 25 | 13.64% |
| 30 Jun, 17 | 104 | -9.57% | 25,609,947 | 4.89% | 96.30% | 1.10% | 72 | - | 22 | -33.33% |
| 31 Mar, 17 | 115 | 15.00% | 24,415,072 | 14.35% | 93.61% | 1.12% | 72 | -19.10% | 33 | 371.43% |
| 31 Dec, 16 | 100 | 69.49% | 21,351,910 | 37.66% | 91.28% | 1.74% | 89 | 128.21% | 7 | -30.00% |
| 30 Sep, 16 | 59 | 22.92% | 15,510,243 | 0.75% | 72.42% | 1.30% | 39 | -2.50% | 10 | 100.00% |
| 30 Jun, 16 | 48 | 41.18% | 15,395,154 | 5.41% | 74.51% | 1.42% | 40 | 81.82% | 5 | -16.67% |
| 31 Mar, 16 | 34 | 3.03% | 14,605,450 | 41.96% | 72.41% | 2.18% | 22 | -33.33% | 6 | - |
| 31 Dec, 15 | 33 | - | 10,288,591 | - | 57.70% | - | 33 | - | - | - |
Aclaris Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Aclaris Therapeutics's stock was made by Walker Neal on Aug 13 2024, selling 43,548 shares at $0.72 per share (valued at $31.35K). The last insider buy of ACRS was made by Leonard Braden Michael on Aug 05 2024, buying 206,025 shares at $1.24 per share (worth $256.36K).
Aclaris Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 13 | 4 | 325.00% |
| Q2 2024 | 33 | 14 | 235.71% |
| Q1 2024 | 25 | 24 | 104.17% |
| Q4 2023 | - | 1 | - |
| Q3 2023 | 5 | 7 | 71.43% |
| Q2 2023 | 27 | 12 | 225.00% |
| Q1 2023 | 25 | 31 | 80.65% |
| Q4 2022 | - | 14 | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 25 | 13 | 192.31% |
| Q1 2022 | 24 | 20 | 120.00% |
| Q4 2021 | 1 | 2 | 50.00% |
| Q3 2021 | 2 | 4 | 50.00% |
| Q2 2021 | 24 | 47 | 51.06% |
| Q1 2021 | 21 | 25 | 84.00% |
| Q4 2020 | 3 | 6 | 50.00% |
| Q3 2020 | 3 | 4 | 75.00% |
| Q2 2020 | 18 | 14 | 128.57% |
| Q1 2020 | 35 | 23 | 152.17% |
| Q4 2019 | 7 | 12 | 58.33% |
13 total buy trades, and 4 total sell trades (buy/sell ratio of 3.25%) were made by Aclaris Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 11 | - | - |
| Q2 2024 | 10 | - | - |
| Q1 2024 | 2 | - | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | 2 | 1 | 200.00% |
| Q2 2023 | - | 1 | - |
| Q1 2023 | 2 | 16 | 12.50% |
| Q4 2022 | - | 13 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 5 | - |
| Q1 2022 | - | 6 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 33 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 11 open market buy trades and 0 open market sell trades of Aclaris Therapeutics's stocks.
Aclaris Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| GTH | Genetron Holdings Limited |
| IQV | IQVIA Holdings Inc. |
| ICLR | ICON Public Limited Company |
| RDNT | RadNet, Inc. |
| PRE | Prenetics Global Limited |
| QGEN | Qiagen N.V. |
| CSTL | Castle Biosciences, Inc. |
| NEOG | Neogen Corporation |
| OLK | Olink Holding AB (publ) |
| MEDP | Medpace Holdings, Inc. |
| BDSX | Biodesix, Inc. |
| MYGN | Myriad Genetics, Inc. |
| SHC | Sotera Health Company |
ACRS Ownership FAQ
Who Owns Aclaris Therapeutics?
Aclaris Therapeutics is owned by institutional shareholders (72.71%), insiders (2.64%), and public (24.65%). The largest institutional shareholder of Aclaris Therapeutics is BML CAPITAL MANAGEMENT, LLC (18.27% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (1.10% of total shares).
Who are the major institutional shareholders of Aclaris Therapeutics?
Aclaris Therapeutics's major institutional shareholders are BML CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, D. E. SHAW & CO., INC., and ROCK SPRINGS CAPITAL MANAGEMENT LP. The top five shareholders own together 38.11% of the company's share outstanding.
How many Aclaris Therapeutics shareholders are there?
As of Jun 2024, there are 88 institutional shareholders of Aclaris Therapeutics.
What percentage of Aclaris Therapeutics is owned by BML CAPITAL MANAGEMENT, LLC?
BML CAPITAL MANAGEMENT, LLC owns 12.99M shares of Aclaris Therapeutics, representing 18.27% of the company's total shares outstanding, valued at $14.29M (as of Jun 2024).
What percentage of Aclaris Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 4.69M shares of Aclaris Therapeutics (ACRS), compromising 6.60% of the company, valued at $5.16M.
What percentage of Aclaris Therapeutics is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of Aclaris Therapeutics. The company owns 3.34M of the company's shares outstanding (worth $3.67M).